title: [Acute myelogenous leukemia with spontaneous remission simultaneous with improvement of severe infection: report of 2 cases].
authors.forename: Y
authors.initials: Y
authors.lastname: Takatsuka
authors.forename: K
authors.initials: K
authors.lastname: Utsunomiya
authors.forename: H
authors.initials: H
authors.lastname: Kawahata
authors.forename: S
authors.initials: S
authors.lastname: Takeuchi
authors.forename: T
authors.initials: T
authors.lastname: Makino
authors.forename: K
authors.initials: K
authors.lastname: Nakahara
authors.forename: S
authors.initials: S
authors.lastname: Shimotakahara
authors.forename: K
authors.initials: K
authors.lastname: Uozumi
authors.forename: S
authors.initials: S
authors.lastname: Hanada
authors.forename: H
authors.initials: H
authors.lastname: Arima
mesh_terms: D000038:Abscess / Q000150:complications / Q000188:drug therapy*; D000583:Amikacin / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D001004:Anus Diseases / Q000150:complications / Q000188:drug therapy*; D002481:Cellulitis / Q000150:complications / Q000188:drug therapy*; D015377:Cilastatin / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D015378:Imipenem / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D008297:Male; D008875:Middle Aged; D011480:Protease Inhibitors / Q000008:administration & dosage*; D012075:Remission, Spontaneous; D013845:Thienamycins / Q000008:administration & dosage*
chemical_list: D000900:Anti-Bacterial Agents; D011480:Protease Inhibitors; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem; D000583:Amikacin